Clebopride
- Level
- Commodity
- Parent
- 51171800
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171855This classification denotes a dopamine antagonist with the molecular formula C20H24ClN3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I0A84520Y9, chemically known as benzamide, 4-amino-5-chloro-2-methoxy-n-(1-(phenylmethyl)-4-piperidinyl)- but generally known as clebopride, which bears US NIH Compound Identifier 2780. European Medicines Agency schedules Clebopride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06646MIG. The term CLEBOPRIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). World Health Organization schedules clebopride in its Anatomical Therapeutic Chemical (ATC) Classification. CLEBOPRIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clebopride under HS 29333999 and SITC 51574. As of Q4 2014, CLEBOPRIDE remains the US FDA Preferred Term for this commodity. Clebopride bears US NLM identifiers UMLS ID C0055869 and NCI Concept Code C83627. SMILES: CLC1CC(C(=O)NC2CCN(CC2)CC2CCCCC2)C(OC)CC1N.
Same parent
Under 51171800 · 49Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.